(R)-Naproxen Acyl-b-D-glucuronide
CAS112828-15-6
(R)-Naproxen Acyl-b-D-glucuronide (CAS 112828-15-6, C20H22 O9) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 112828-15-6
- Formula
- C20H22 O9
- Mol. weight
- 406.38 g/mol
Chemical Specifications
Identifiers
| CAS number | 112828-15-6 |
|---|---|
| Product name | (R)-Naproxen Acyl-b-D-glucuronide |
| Chinese name | (R)-萘普生酰基-Β-D-葡糖苷酸 |
| Synonyms | (R)-Naproxen Acyl--D-glucuronide |
| Chinese synonyms | (R)-萘普生酰基-Β-D-葡糖苷酸 |
| Molecular formula | C20H22 O9 |
| Molecular weight | 406.38 g/mol |
Physical and chemical properties
| Melting Point | 128-130 ( ℃ ) |
|---|
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of (R)-Naproxen Acyl-b-D-glucuronide?
The CAS Registry Number of (R)-Naproxen Acyl-b-D-glucuronide is 112828-15-6. (R)-Naproxen Acyl-b-D-glucuronide is also known as (R)-Naproxen Acyl--D-glucuronide.
What is the molecular formula and molecular weight of (R)-Naproxen Acyl-b-D-glucuronide?
The molecular formula of (R)-Naproxen Acyl-b-D-glucuronide is C20H22 O9, and its molecular weight is 406.38 g/mol.
How can I request a quotation for (R)-Naproxen Acyl-b-D-glucuronide?
Send an inquiry for (R)-Naproxen Acyl-b-D-glucuronide (CAS 112828-15-6) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for (R)-Naproxen Acyl-b-D-glucuronide
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.